NCT00851344 - Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG

GSK835726 (10mg)

GSK835726 (10mg) tablet

DRUG

GSK835726 (50mg)

GSK835726 (50mg) tablet

DRUG

GSK835726 (100mg)

GSK835726 (100mg) tablet

DRUG

Cetirizine (10mg)

Cetirizine (10mg) tablet as positive control

OTHER

Placebo

Placebo to match active

Trial Locations (1)

GSK Investigational Site, Hanover